PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline COMMENT
Authors:
- William P. TewWTWilliam P. Tew
- Christina LacchettiCLChristina Lacchetti
- Annie EllisAEAnnie Ellis
- Kathleen MaxianKMKathleen Maxian
- Susana BanerjeeSBSusana Banerjee
- Michael BookmanMBMichael Bookman
- Monica Brown JonesMJMonica Brown Jones
- Jung-Min LeeJLJung-Min Lee
- Stéphanie LheureuxSLStéphanie Lheureux
- Joyce F. LiuJLJoyce F. Liu
- Kathleen N. MooreKMKathleen N. Moore
- Carolyn MullerCMCarolyn Muller
- 1 December 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 75 (12) , 739-+